Global Cryotherapy and Cryosurgery Market Size

The global cryotherapy and cryosurgery market size was valued at USD 2.75 billion in 2025 and it is expected to reach USD 6.02 billion by 2034 from USD 3 billion in 2026, growing at a CAGR of 9.1%. From 2026 to 2034.

Cryotherapy or Cryosurgery involves using extreme cold to freeze and remove abnormal tissue for both external and internal treatments for treating many skin conditions and certain types of cancers like cervical, prostate, and liver cancer; therefore, also called cryoablation. Cryotherapy and Cryosurgery are pathological processes carried out at low temperatures to remove abnormal tissue. In literal meaning, Cryosurgery involves performing cryotherapy using an open surgical approach, with high-pressure liquid nitrogen or argon gas flowing through a cryoprobe. It is also used to treat certain conditions that could turn into cancer. Different substances that create intense cold conditions in cryotherapy include liquid nitrogen, nitrous oxide, and argon gas.

MARKET DRIVERS

One of the primary growth factors in the global cryotherapy and cryosurgery market is the minimal postoperative risk of non-target body parts.

The global cryotherapy and cryosurgery market growth is driven by continuous innovation and technical development. In addition, increased awareness and consciousness about skin and related disorders and an increase in cancer therapies are driving the cryotherapy and cryosurgery market. Compared to traditional surgery, cryosurgery is a minimally invasive treatment with less pain, less blood loss, and a lower risk of damaging healthy tissue near abnormal cells since it does not require follow-up or destruction of the target, because of which it is also increasingly being used for benign tumors treatment. It is also used for the treatment of precancerous and malignant tumors through total try destruction, which is achieved by a dual process of tissue water crystallization, and ischemia caused by vascular thrombosis, requiring persistent monitoring, Tumors such as seborrheic keratosis, hyperplasias, sebaceous adenomas, and verrucous-looking hamartomas epithelial tumors; Vascular tumors like senile angiomas, pyogenic granuloma, angiokeratomas, and lymphangiomas; Mesenchymal tumors like mucoid or mucinous cutaneous pseudocysts and fibrous histiocytoma are well treated with cryotherapy to improve suppuration problems without risk.

Furthermore, the demand is projected to be positively influenced by untapped markets in emerging economies such as India and China and the rising incidence of cancer therapies. Technological advances and medical research into the effectiveness of cryotherapy and Cryosurgery in treating other diseases will drive global market demand in the coming years. Smaller incisions, a shorter hospital stay, faster wound healing, less inflammation, surgical wounds, and a reduced chance of complications are all benefits of Cryosurgery over traditional surgeries. Cryosurgery's advantages have led to accelerated popularity in recent years, which has fuelled its market growth. Furthermore, technological advances and medical research examining the feasibility of cryotherapy and Cryosurgery in treating other diseases will increase world market demand for the foreseeable future. Cryogen is an innovative and leading cryosurgical team due to its practical design and reduced health risks.

MARKET RESTRAINTS

Scientific evidence is not yet available for the long-term benefit of Cryosurgery in treating early-stage cancers. Additionally, more prolonged exposure to frozen liquid nitrogen can be fatal, so medical experts have refrained from using it in children, patients with high blood pressure, and pregnant women. The factors mentioned above are slowly hindering the growth rate of the market. In addition, a few complications like bleeding or cramping after cryotherapy are seen in the patients, usually around bone fractures and the cervix, or could even lead to nerve damage resulting in scarring, loss of sensation, swelling, and skin infection.

Due to uncontrolled freezing during cryotherapy sessions, adjacent tissue, bones, and muscles may numb. Furthermore, prolonged exposure to freezing liquid nitrogen can be dangerous, so medical professionals have advised against using it on children, people with high blood pressure, or pregnant women.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Technique Insights

Cryoprobe has the most considerable growth. High-pressure argon gas or liquid nitrogen flows through a needle-like applicator called a cryoprobe during cryotherapy treatment, creating an intense cold on the diseased cell or tissue. In addition, large plugs of mucus and blood clots, which are not removable with flexible grasping forceps, can be removed by cryoprobes.

Forceps have also been increasingly used in cryotherapy, leading to its high estimation of revenue in market growth. They treat wounds around delicate areas with a cotton-tipped applicator dipped in liquid nitrogen, resulting in less pain and collateral damage than traditional methods. The tweezers are immersed directly in liquid nitrogen to treat more delicate areas.

By Type Insights

The cryosurgery devices segment is expected to rise faster during the forecast period. Cryosurgery is becoming more common due to its benefits, such as fewer side effects and lower costs. The most common Type of treatment is Cryosurgery, as this procedure helps treat various cancers and skin diseases. At the same time, icepack therapy is foreseen to grow the fastest in this segment. The ice pack helps constricts local blood vessels by lowering tissue temperature, which decreases blood flow and cell metabolism. Therefore, it helps limit hemorrhage and cell death in acute traumatic injuries. The blood vessels are later slowly dilated due to an increase in tissue temperature after about 20 minutes of ice, leading to reactive vasodilation.

By Application Insights

 Cancer therapy is the most widely used sector for cryotherapy. Cryoprobe is used in this method of treating tumors inside the body for freezing the tumor tissue, causing cells in the treated area to die. Still, skin disease treatments are expected to develop at the highest rate due to recent technological advancements. Liquid nitrogen is applied for skin treatments directly to the abnormal area, a specific point on the skin, using shallow temperatures to freeze and kill the diseased area of the skin.

By Devices Insights

Based on devices with the highest sales share, the cryogun segment dominated the overall market. The high use of this unit in cryotherapy and product growth are two major factors leading to this segment's vast market share. Furthermore, the high prevalence of cancer and dermatologic conditions are likely significant factors driving cryogun demand. Furthermore, cryogen is used in MRI machines which use liquid helium for cryogenic cooling, freezing blood and tissue samples, and many more applications, which is the reason for its anticipation to show a high growth rate in the market over the forecast period.

REGIONAL ANALYSIS

The North American cryotherapy and cryosurgery market is expected to hold a significant share in the global market during the forecast period due to the presence of market leaders, well-developed healthcare infrastructure, and extensive use of sprains in sports-related injuries treatment. The regional market is primarily driven by well-established healthcare infrastructure, spending high health per capita, and high levels of disposable income, since it has almost 69% of all cryotherapy centers in the world, according to a research study. In addition, North America is the largest regional market in sales due to the participation of skilled professionals, the increasing use of whole-body cryotherapy, the adoption of cryotherapy for cancers and skin conditions, rising cancer prevalence, and the use of minimally invasive surgery.

The European cryotherapy and cryosurgery market ranks second in the global market in terms of sales and market share. The rising incidence of cancer and a booming healthcare sector equipped with advanced treatment options are propelling the market forward. This European market growth is also attributed to the rapid development of healthcare infrastructure, untapped opportunities, rising levels of disposable income, and the growing awareness of Cryosurgery in cancer and skin treatments. Additionally, the Approval of new products in developing markets highly fragmented global cryotherapy market with major players, and quick collaborations of businesses following the prevailing trends of associations and associations to provide the best quality services over the long term are the determining factors for colossal market growth. Furthermore, increased healthcare investments in Europe promote market growth.

The Asia Pacific cryotherapy and cryosurgery market is expected to rise the most during the forecast period. The emergence of a large target market in developing markets such as India and China and increased efforts by leading players to ensure the availability of cryotherapy products in these countries are credited with this high growth. In addition, the Asia Pacific is the fastest-growing region due to increasing expenditure on research and development, innovations, and advancements in medical fields. Furthermore, rising awareness, growth of base installation of cryosurgical equipment, growing demand for minimally invasive therapies, and the use of Cryosurgery in combination with other therapies for more efficient and enhanced treatments, mainly the use of cryochambers in countries such as China, and Japan, are some of the reasons prophesied to drive the market growth.

The major market players are expanding their product portfolio to offer new or technologically advanced products for targeting consumers as a result of fierce competition might be the reason for the high growth rate estimated to be showing during the forecast period in the regions of Latin America cryotherapy and cryosurgery market and MEA cryotherapy and cryosurgery market.

KEY MARKET PLAYERS 

Some of the noteworthy companies operating in the global cryotherapy and cryosurgery market profiled in the report are Impact Cryotherapy, Galil Medical, Inc., HealthTronics, Inc., KryoLife, Inc., Medtronic, GRAND Cryo LLC, Erbe USA, Wallach Surgical Devices, MedGyn Products, Inc. and CoolTouch, Inc.

RECENT HAPPENINGS IN THIS MARKET

• In November 2024, Florida's largest liquid nitrogen distributor, the Cryo Group, LLC, acquired the assets of InCryo Systems, Inc., making it the premier vertically integrated provider of cryogenic solutions in the Southeastern United States, with the vision to make Cryo Group a leading provider of cryogenic solutions to a diverse portfolio of industries like agriculture, food, and beverage, medical, aerospace and automotive.

• In April 2024, Thermo Fisher launched next-generation cryotransmission electron microscopes to support advanced research and acceleration of drug discovery, potential cures, and diagnostic research, including a suite of sample handling and automation technologies, through an electron microscope at the Center for Cellular and Molecular Biology (CCMB)

MARKET SEGMENTATION

This market research report on the global cryotherapy and cryosurgery market has been segmented and sub-segmented based on technique, Type, application, devices, and region.

By Technique

• Spray

• Forceps

• CryoProbe

By Type

• Cryosurgery

• Icepack Therapy

• Cryogenic Chamber Therapy

By Application

• Cancer Therapy

• Skin Disease

By Devices

• Cryogun

• Probes

• Cryogen

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East and Africa